Intuitive Surgical, Inc. (ISRG) Institutional Ownership & Insider Trading

2,238 institutions reported holding Intuitive Surgical, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 81 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason

ISRGIntuitive Surgical, Inc.Follow ISRG — free

Medical Instruments & Supplies · Healthcare

—

Price chart with a free account

Market cap: 156.8B
P/E TTM: 54.8
Dividend yield: —
52-week: —
Next earnings: 20 Jan, in 88 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

2,238 institutions held 88.5% of the shares. Across filers that reported both quarters, shares held changed +0.3%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	2,238	307	+0.3%	788	121	767	173
Mar 26	2,280	292	-1.1%	852	103	693	196
Dec 25	2,353	299	-0.3%	848	250	578	77
Sep 25	2,060	294	-1.5%	726	97	672	224
Jun 25	2,217	302	-0.3%	866	162	561	80
Mar 25	2,126	297	-0.8%	782	155	582	92
Dec 24	2,051	303	-2.9%	680	109	565	51
Sep 24	1,886	296	-3.6%	614	167	516	49

Intuitive Surgical, Inc. — questions

Who owns Intuitive Surgical, Inc. stock?: 2,238 institutions reported Intuitive Surgical, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.7%), VANGUARD CAPITAL MANAGEMENT LLC (6.7%), STATE STREET CORP (4.6%).
Are Intuitive Surgical, Inc. insiders buying or selling?: 81 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Intuitive Surgical, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.